Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guohong Han

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Gut|November 12, 2018
Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational studyYong Lv, Luo Zuo, Xuan Zhu, et al.
Hepatology International|November 15, 2024
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and managementAkash Shukla, Don C Rockey, Patrick S Kamath, et al.
European Radiology|April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolizationDongdong Xia, Qiuhe Wang, Wei Bai, et al.
Journal of Hepatology|January 21, 2019
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational studyQiuhe Wang, Dongdong Xia, Wei Bai, et al.
The Lancet. Gastroenterology & Hepatology|May 23, 2025
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYinghong Shi, Guohong Han, Jian Zhou, et al.
Liver Cancer|January 14, 2021
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
JHEP Reports : Innovation in Hepatology|January 6, 2025
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study<sup>☆</sup>Dongdong Xia, Wei Bai, Qiuhe Wang, et al.
Liver Cancer|October 30, 2023
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)Zheng Wang, Huichuan Sun, Jian Zhou, et al.
Liver Cancer|October 9, 2025
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Gut|November 12, 2018
Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational studyYong Lv, Luo Zuo, Xuan Zhu, et al.
Hepatology International|November 15, 2024
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and managementAkash Shukla, Don C Rockey, Patrick S Kamath, et al.
European Radiology|April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolizationDongdong Xia, Qiuhe Wang, Wei Bai, et al.
Journal of Hepatology|January 21, 2019
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational studyQiuhe Wang, Dongdong Xia, Wei Bai, et al.
The Lancet. Gastroenterology & Hepatology|May 23, 2025
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYinghong Shi, Guohong Han, Jian Zhou, et al.
Liver Cancer|January 14, 2021
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
JHEP Reports : Innovation in Hepatology|January 6, 2025
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study<sup>☆</sup>Dongdong Xia, Wei Bai, Qiuhe Wang, et al.
Liver Cancer|October 30, 2023
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)Zheng Wang, Huichuan Sun, Jian Zhou, et al.
Liver Cancer|October 9, 2025
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
Pageof 20